Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**PASCALLERG** is a homeopathic combination product formulated to relieve symptoms of *hay fever* and a wide range of other *allergies*, including sneezing, wheezing, dyspnea, itching of the skin, and eye irritation. It is designed as a non-drowsy, gentle alternative to antihistamines and conventional allergy medications, and is suitable for both children (ages 1+) and adults. The homeopathic tablets contain: - Chromium kali sulphuricum Trit. 2X (25 mg) - Acidum formicicum Trit. 2X (2.5 mg) - Gelsemium sempervirens Trit. 2X (2.5 mg) Common indications include seasonal allergies (pollen, ragweed), allergic rhinitis, and reactions from animal dander, dust, foods, insect stings, medicines, and chemicals. The mechanism of action is consistent with general homeopathic principles—purportedly stimulating the body’s self-healing response—rather than a defined pharmacological target. PASCALLERG acts as a symptom reliever, not an immunotherapy, antihistamine, or decongestant[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PASCALLERG.